Three More Repurposed Drugs Identified as Useful Against COVID
Brian Wang |
October 27, 2020 |
Three drugs out of 4000 existing drugs were identified as possibly effective against COVID. They are candidates for clinical trials. They are the antimalarial drug amodiaquine, the anti-psychotic zuclopenthixol, and the blood pressure medication nebivolol.
University of New Mexico researcher Oprea and his team published in ACS Pharmacology & Translational Science, reported that an older antimalarial drug called amodiaquine was effective in eradicating the virus in test tube experiments.
They look through a library of approved drugs and found something like Remdesivir but is also much cheaper.
The anti-psychotic zuclophentixol and a blood pressure medication called nebivolol also cleared the virus in the experiments.
Having more COVID drugs gives doctors more options for drug treatment cocktails.
SOURCES- University of New Mexico
Written By Brian Wang, Nextbigfuture.com
Brian Wang is a Futurist Thought Leader and a popular Science blogger with 1 million readers per month. His blog Nextbigfuture.com is ranked #1 Science News Blog. It covers many disruptive technology and trends including Space, Robotics, Artificial Intelligence, Medicine, Anti-aging Biotechnology, and Nanotechnology.
Known for identifying cutting edge technologies, he is currently a Co-Founder of a startup and fundraiser for high potential early-stage companies. He is the Head of Research for Allocations for deep technology investments and an Angel Investor at Space Angels.
A frequent speaker at corporations, he has been a TEDx speaker, a Singularity University speaker and guest at numerous interviews for radio and podcasts. He is open to public speaking and advising engagements.
Read next:
Star Trek, Intel and Boeing Lost Their Engineering Mojo »
« Ultrahigh-res OLED Displays With Over 10,000 Pixels Per Inch
Comments
Post a Comment